In contrast, even though downregulation of CR2, PIM2, CXCL13 and HLA-DPB1 were demonstrated in all DLBCL and in EBV-negative DLBCL cases, 10 new genes were differentially downregulated. This evidence concerns the gene PIM2 and diffuse large B-cell lymphoma.